Patents Assigned to Bigfoot Biomedical, Inc.
  • Patent number: 11116899
    Abstract: One or more embodiments of the disclosure relate, generally, to a diabetes management system. The diabetes management system may include a computing device that is configured to receive data relating to prior insulin use of a user and calculate a sliding scale glucose correction based, at least in part, on the data relating to prior insulin use.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: September 14, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11096624
    Abstract: Systems, methods, and devices provide alarms and alerts in an on-body networked diabetes management system. Methods may include receiving glucose sensor data from a continuous glucose monitor and determining a dosage of insulin delivery based at least in part on the glucose sensor data. The method may include detecting an alarm or alert condition, and sending a wireless communication regarding the alarm or alert condition to a remote user-interface device. The method may include triggering an audible, visual, or haptic alarm or alert on the insulin delivery device unless an acknowledgement of the alarm or alert condition is received within a predetermined period of time.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: August 24, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Sabine Kabel-Eckes, Shannon Sieber, Jeff Boissier, George Crothall, Yean Wah Chan
  • Patent number: 11090439
    Abstract: One or more embodiments of the disclosure are related, generally, to a reusable accessory for a manual medication delivery device. Such a reusable accessory may include a wireless communication interface, a detection circuitry, and a recommendation system. In one or more embodiments, an adapter may be configured to reversibly couple such a reusable accessory to a manual medication delivery device. Dosing events may be detected that are associated with dosing at the manual medication delivery device. Dose recommendations may be provided responsive to analyte measurements and/or dosing events.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: August 17, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11083852
    Abstract: One or more embodiments of the disclosure relate, generally, to a system to assist with manual dosing of insulin. Such a system may include a glucose sensor system, a reusable insulin dosing detector, and a recommendation system. The reusable insulin dosing detector may be configured to be reversibly connectable to a disposable component that may form part of an insulin manual delivery assembly. The reusable insulin dosing detector may be configured to detect insulin delivery associated with the insulin manual delivery assembly. The recommendation system may be configured to analyze blood glucose data and determine adjustments to insulin therapy settings.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: August 10, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11077243
    Abstract: One or more embodiments relate, generally, to a reusable accessory for a medication injection pen. Such a reusable accessory may be adapted to be reversibly attached to a medication injection pen, and configured to detect an event associated with an injection of medication from the medication injection pen. It may also be configured to determine a percentage of medication that remains active for injection by the medication injection pen based on timing information and dosing event information.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: August 3, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11049601
    Abstract: A method for managing therapy data using computing nodes is disclosed. A computing node is associated with a blockchain identifying therapy data and features. The method includes: obtaining, by a first computing node from a first medical device, first therapy data, the first computing node being associated with a first blockchain; validating the first therapy data using features associated with the first blockchain; and in response to validating the first therapy data, adding the first therapy data to the first blockchain; receiving a request from a second medical device to obtain the first therapy data from the first block chain; providing, from the first computing node to the second medical device, and in response to receiving the request, the first therapy data to the second medical device, wherein the therapy data is used by the second medical device to provide a patient therapy recommendation.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: June 29, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Kevin S. Lee, Corydon A. Hinton, Alexandra Elena Constantin
  • Patent number: 11033682
    Abstract: A method of insulin delivery, the method may include obtaining one or more blood glucose readings of a user, and, based on the blood glucose readings, generating a set of insulin delivery actions that may include delivery of a baseline basal rate or predefined variations of the baseline basal rate. The method may also include monitoring previous insulin delivery actions to the user to determine whether the previous insulin delivery actions include insulin beyond a threshold amount, where the previous insulin delivery actions may include delivery of the baseline basal rate or predefined variations of the baseline basal rate, and, based on the previous insulin delivery actions including insulin beyond the threshold amount, adjusting the set of insulin delivery actions.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: June 15, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough
  • Patent number: 11027073
    Abstract: A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: June 8, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Patent number: 11027063
    Abstract: An insulin delivery monitoring system that includes an insulin delivery device and a controller configured to perform or control performance of operations. A method of insulin delivery include determining a correction dose of insulin and triggering an alert.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: June 8, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough
  • Patent number: 11000645
    Abstract: Some embodiments of a portable medical device, such as an infusion pump, can receive an external reference signal (e.g., a radio, cellular and/or satellite signal) to provide an automatic time-setting and maintenance operation. In these circumstances, the medical device can maintain accurate time and date information even in the event of a power interruption, a time-zone change and/or an internal clock error, for example. In this manner, the portable medical device provides safe operation and added convenience to the user.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: May 11, 2021
    Assignee: BIGFOOT BIOMEDICAL, INC.
    Inventors: Mark C. Estes, Mitchell Wenger
  • Patent number: 10994078
    Abstract: Some embodiments of an infusion pump assembly may be equipped with one or more components to facilitate wireless operation of an infusion pump via a user-operated mobile device. In some embodiments, the mobile device and/or the infusion pump may prompt the user to confirm acceptance of a wirelessly communicated command to prevent an operation by the infusion pump (e.g., a dispensation of medicine) that is not desired by the user.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: May 4, 2021
    Assignee: BIGFOOT BIOMEDICAL, INC.
    Inventors: Mark C. Estes, Wenkang Qi, David Thrower
  • Patent number: 10987464
    Abstract: One or more embodiments of the disclosure relate, generally, to a pen cap for a manual insulin delivery device. Such a pen cap may include a wireless communication interface, a detection circuit, a user interface, and a processor and memory. The detection circuit may be configured to detect cappings and decappings of the pen cap from a manual insulin delivery device. Timing information and recommendations related to capping and decapping of the pen cap may be presented to a user.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: April 27, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 10987468
    Abstract: A multi-modal medicine delivery system in which some embodiments can be configured to control dispensation of medicine according to any of a plurality of delivery modes, such as by closed-loop delivery modes and open-loop delivery modes, and according to a secondary feedback loop to determine user-specific settings related to dosage delivery.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: April 27, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough
  • Patent number: 10896245
    Abstract: In one implementation, an insulin delivery system using an on-body network includes an insulin delivery device that is adapted to administer dosages of insulin to a patient; a controller that is adapted to control operation of the insulin delivery device, to establish a first network connection in which the controller acts in a central role, and to establish a second network connection in which the controller acts in a peripheral role; one or more peripheral devices that are adapted to generate patient data related to blood glucose levels and to transmit the patient data wirelessly over the first network connection, the peripheral devices acting in a peripheral role over the first network connection; and a mobile application installed on a mobile computing device that is programmed to communicate with the controller over the second network connection, the mobile application communicating in a central role over the second network connection.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: January 19, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: George Crothall, Yean W. Chan
  • Patent number: 10881793
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to a user provided insulin delivery amount, including a user provided insulin delivery amount that varies from a recommended insulin delivery amount.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: January 5, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Patent number: 10881792
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to a user provided insulin delivery amount, including a user provided insulin delivery amount that varies from a recommended insulin delivery amount. Methods and systems may include locking out automated modification of a baseline basal rate of insulin for the user for the time period after a user provides an insulin delivery amount.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: January 5, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Patent number: D911355
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: February 23, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Sabine Kabel-Eckes, Jeff Boissier, Jennifer Martin Block, Bryan Mazlish
  • Patent number: D920343
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: May 25, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventor: Jacob Bowland
  • Patent number: D928199
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: August 17, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Sabine Kabel-Eckes, Jeff Boissier, Bethany Leigh Salmon
  • Patent number: D930033
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: September 7, 2021
    Assignee: Bigfoot Biomedical, Inc.
    Inventor: Jacob Bowland